These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33129040)

  • 21. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes - a cross-sectional study.
    Aggerholm-Pedersen N; Jellesmark Thorsen LB; Møller Tauber N; Tingdal Danielsen J; Løppenthin K; Borgquist S; Johansen C; Zacharie R
    Acta Oncol; 2024 Jun; 63():518-525. PubMed ID: 38946287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.
    Sessa C; Cortes J; Conte P; Cardoso F; Choueiri T; Dummer R; Lorusso P; Ottmann O; Ryll B; Mok T; Tempero M; Comis S; Oliva C; Peters S; Tabernero J
    ESMO Open; 2022 Feb; 7(1):100339. PubMed ID: 34953404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.
    Moreno L; Pearson ADJ; Paoletti X; Jimenez I; Geoerger B; Kearns PR; Zwaan CM; Doz F; Baruchel A; Vormoor J; Casanova M; Pfister SM; Morland B; Vassal G;
    Nat Rev Clin Oncol; 2017 Aug; 14(8):497-507. PubMed ID: 28508875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
    Tan AC; Ashley DM; Khasraw M
    Clin Cancer Res; 2020 Jul; 26(13):3100-3103. PubMed ID: 32312892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey.
    Neamţiu L; Martos C; Giusti F; Negrão Carvalho R; Randi G; Dimitrova N; Flego M; Dyba T; Bettio M; Gavin A; Visser O;
    Eur J Public Health; 2022 Apr; 32(2):311-315. PubMed ID: 34935934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures.
    van Koningsbruggen-Rietschel S; Dunlevy F; Bulteel V; Hayes K; Verbrugge A; Janssens HM; Dufeu N; Simmonds NJ; Dupont LJ; Downey DG
    Trials; 2021 Aug; 22(1):578. PubMed ID: 34454570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.
    de Joode K; Tol J; Hamberg P; Cloos M; Kastelijn EA; Borgers JSW; Nuij VJAA; Klaver Y; Herder GJM; Mutsaers PGNJ; Dumoulin DW; Oomen-de Hoop E; van Diemen NGJ; Libourel EJ; Geraedts EJ; Bootsma GP; van der Leest CH; Peerdeman AL; Herbschleb KH; Visser OJ; Bloemendal HJ; van Laarhoven HWM; de Vries EGE; Hendriks LEL; Beerepoot LV; Westgeest HM; van den Berkmortel FWPJ; Haanen JBAG; Dingemans AC; van der Veldt AAM;
    Eur J Cancer; 2022 Jan; 160():261-272. PubMed ID: 34799210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of COVID-19 pandemic on paediatric surgical training across Europe.
    Zambaiti E; Cascio S; Pelizzo G; Siles Hinojosa A; de Augustin Asensio JC; Fortmann C; Lacher M; Malowiecka M; Czauderna P; Arneitz C; Till H; Glenisson M; Bonnard A; Hoel AT; Bjørnland K; Hukkinen M; Demetrios G; Zavras N; Reusens H; Steyaert H; Pevere A; Aubert O; Pio L
    Br J Surg; 2022 Nov; 109(12):1326-1328. PubMed ID: 36094547
    [No Abstract]   [Full Text] [Related]  

  • 33. Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.
    Bhatt AS; Lindholm D; Nilsson A; Zaozerska N; Claggett BL; Vaduganathan M; Kosiborod MN; Lam CSP; Hernandez AF; Martinez FA; Inzucchi SE; Shah SJ; de Boer RA; Desai A; Jhund PS; Langkilde AM; Petersson M; McMurray JJV; Solomon SD
    Am Heart J; 2023 Sep; 263():133-140. PubMed ID: 37220822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development.
    Beck L; Witt R; Nesper-Brock M; Milde T; Hettmer S; Frühwald MC; Rössig C; Fischer M; Reinhardt D; Taylor LA; Riedel C; Witt O; van Tilburg CM
    Clin Pharmacol Ther; 2021 Oct; 110(4):1025-1037. PubMed ID: 34050933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality.
    Unger JM; Stires H; Levit LA; Stewart M; McKelvey BA; Canin B; Dressler E; Flaherty K; Fredette P; Jones L; McCann P; Miller T; Onitilo AA; Palmieri F; Patel T; Paul R; Smith GL; Bruinooge SS; Garrett-Mayer E; Lei XJ; Alva A; Schenkel C
    JCO Oncol Pract; 2023 Oct; 19(10):907-916. PubMed ID: 37643386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of COVID-19 on otolaryngology research: a cross-sectional analysis of discontinued trials.
    Rucker BM; Sajjadi NB; Brame LS; Vassar M; Hartwell ML
    J Osteopath Med; 2022 Apr; 122(8):393-399. PubMed ID: 35363445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the COVID-19 pandemic on child health and the provision of Care in Paediatric Emergency Departments: a qualitative study of frontline emergency care staff.
    Conlon C; McDonnell T; Barrett M; Cummins F; Deasy C; Hensey C; McAuliffe E; Nicholson E
    BMC Health Serv Res; 2021 Mar; 21(1):279. PubMed ID: 33766026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of SARS-CoV-2 Pandemic and Strategies for Resumption of Activities During the Second Wave of the Pandemic: A Report From Eight Paediatric Hospitals From the ECHO Network.
    Indolfi G; Stivala M; Lenge M; Diaz Naderi R; McIntosh J; Llandrich RC; Gannon J; McGreevy KS; Trapani S; Miettinen P; Lahdenne P; Desborough L; Pavare J; van Rossum A; Zyska D; Resti M; Zanobini A
    Front Public Health; 2021; 9():630168. PubMed ID: 33981662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov.
    Hutchinson N; Klas K; Carlisle BG; Kimmelman J; Waligora M
    PLoS One; 2022; 17(1):e0262114. PubMed ID: 35061758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncological care organisation during COVID-19 outbreak.
    Onesti CE; Rugo HS; Generali D; Peeters M; Zaman K; Wildiers H; Harbeck N; Martin M; Cristofanilli M; Cortes J; Tjan-Heijnen V; Hurvitz SA; Berchem G; Tagliamento M; Campone M; Bartsch R; De Placido S; Puglisi F; Rottey S; Müller V; Ruhstaller T; Machiels JP; Conte P; Awada A; Jerusalem G
    ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32847836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.